Viewing Study NCT04921527


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT04921527
Status: RECRUITING
Last Update Posted: 2024-10-18
First Post: 2021-06-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
Sponsor: Chipscreen Biosciences, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module